Navigation Links
Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc.
Date:9/18/2008

at these growth trends will be sustained in the future. We expect to have more frequent communication with our shareholders, and hope to broaden the awareness of Yongye's accomplishments in the investment community.

Unleashing the Productivity of China's Agricultural Sector

While China's population is increasing, the amount of arable land available for farming is decreasing. China's farmland is currently being used at close to capacity levels to meet domestic demand. Increasing affluence and a rising concern about food quality and safety have led to greater demand for organic plant and animal nutrients. The need to use land efficiently has led to a need to improve productivity throughout the agricultural sector.

Yongye employs its proprietary technology to produce what we believe are the most effective fulvic acid-based plant and animal nutrient products available today. Our products deliver compelling returns by boosting productivity of farms and dairy cows, reducing the usage of other fertilizers and pesticides, improving the stability and quality of the soil. For dairies, we reduce the need for expensive antibiotics and health supplements. We have enjoyed an exceptionally strong demand from farmers once they try and experience the benefits of our products, and believe there is significant unmet demand for our products throughout China.

Scalable Distribution Model Drives Geographic Expansion

We believe that Yongye's scalable distribution model, which employs a sales network of branded stores that are owned and operated by independent, local entrepreneurs but utilize a consistent Yongye branding and promotional model, is another key cornerstone of our success. This year our goal was to significantly grow our branded store count and distribution footprint, and I am very pleased to report that the number of branded stores grew from 200 at the end of 2007 to 775 at the end of June 2008. Our management team is now deploying our streng
'/>"/>

SOURCE Yongye Biotechnology International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
2. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
3. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
4. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
5. BioMaxx Systems Inc. Signs Engagement Letter With Alcofuel Technologies for Provision of an Ethanol Micro-Refinery
6. IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma
7. XTL Receives Staff Letter From NASDAQ
8. XTL Receives Staff Letter From NASDAQ; XTL may Transfer its ADR Listing to the NASDAQ Capital Market
9. Pharmos Issues Letter to Shareholders
10. Coherent, Inc. Receives Expected Letter from NASDAQ
11. Neurocrine Receives Approvable Letter for Indiplon Capsules with Additional Safety and Efficacy Data Required by FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... May 17, 2013 Tooth decay is an ... active signs of the disease. The World Health Organization says ... 100% of adults have cavities. What are the long-term effects ... showing a strong connection between the oral bacterial imbalance and ... disease so rampant, yet it is also 100% preventable? Answer: ...
(Date:5/16/2013)... Zealand (PRWEB) May 16, 2013 In late ... invited to speak to doctors in China about Appearance ... and NZ, this was her first trip to lecture in ... Hart visited Guangzhou and Fuzhou, home to 12 and 7 ... China is very high at this point in time. As ...
(Date:5/16/2013)... Ore. , May 16, 2013  HealthSparq, ... many of the nation,s largest regional health plans, ... America,s Health Insurance Plans (AHIP) Institute 2013 conference ... highlight survey results showing how health insurance companies ... for the consumer and marketplace demands for increased ...
(Date:5/16/2013)... May 16, 2013 On average, developing ... over one billion dollars. Despite this investment, less than ... this high, is your clinical trial design optimally structured ... best outcomes? , Dr. Frederic Sax, Global Head of ... the use of data, information and technology in upfront ...
Breaking Biology Technology:Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 2Seeing the Future: How a Revolutionary New Bacterial Screening Device Can Predict a Patient’s Future for Tooth Decay 3HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 2HealthSparq to Reveal New Healthcare Transparency Benchmark Study at AHIP Institute 2013 3Optimizing Clinical Trials Outcomes through Computer Assisted Design, New Life Science Webinar Hosted by Xtalks 2
... 2008 NFPA 1584 establishes the routine use of Pulse CO-Oximetry as a ... the dangers of CO ... Poisoning, ... and Measure-Through Motion and Low,Perfusion pulse oximetry, announced today that the National ...
... Endpoint for Phase 3 Registration Trial No Later Than ... ... Inc. (Nasdaq:,FVRL), a biopharmaceutical company developing patient-specific, active,immunotherapies for the treatment of ... 2007. For the quarter and year,ended December 31, 2007, the Company reported ...
... U.S. Department of Energy,s Ames ,Laboratory have come ... and distribute ,the massive amounts of data that ... the world. The new technology, a three-dimensional photonic ... multiple ,wavelength channels (wavelengths of light) traveling along ...
Cached Biology Technology:National Fire Protection Association (NFPA) Sets New National Standard for CO Screening by Pulse CO-Oximetry(TM) 2National Fire Protection Association (NFPA) Sets New National Standard for CO Screening by Pulse CO-Oximetry(TM) 3National Fire Protection Association (NFPA) Sets New National Standard for CO Screening by Pulse CO-Oximetry(TM) 4Favrille Reports Fourth Quarter and Year End 2007 Financial Results 2Favrille Reports Fourth Quarter and Year End 2007 Financial Results 3Favrille Reports Fourth Quarter and Year End 2007 Financial Results 4Favrille Reports Fourth Quarter and Year End 2007 Financial Results 5Favrille Reports Fourth Quarter and Year End 2007 Financial Results 6Favrille Reports Fourth Quarter and Year End 2007 Financial Results 7Favrille Reports Fourth Quarter and Year End 2007 Financial Results 8Favrille Reports Fourth Quarter and Year End 2007 Financial Results 9New filter clears up fiber optic communications 2New filter clears up fiber optic communications 3
(Date:5/16/2013)... SPARTANBURG, S.C. , May 16, 2013 /PRNewswire/ ... film in combination with a custom thin film ...  the highest forensic quality roll image in the ... market today. Sherlock, an Appendix F Mobile ID ... provides a 95% reduction in size and weight ...
(Date:5/16/2013)... the bone marrow in the liver, the spleen ... show that a specific type of immune cell facilitates ... hematopoiesis is essential for the function of the immune ... the liver and the spleen. Later the process is ... serves as the sole source of blood cells for ...
(Date:5/16/2013)... conservationist working in Cameroon and the manager of San ... awarded the prestigious Whitley award. The Whitley award ... Green Oscars" because it celebrates the extraordinary achievements of ... countries. Abwe was selected for the award due ... Ebo Forest and its wildlife inhabitants., HRH The Princess ...
Breaking Biology News(10 mins):Herpes infections: Natural killer cells activate hematopoiesis 2Cameroon researcher wins prestigious 'Green Oscar' 2Cameroon researcher wins prestigious 'Green Oscar' 3
... 2008 American Society for Microbiology (ASM) sanofi-aventis U.S. ... Director, WWAMI Regional Center of Excellence for Biodefense ... by an unrestricted grant from sanofi-aventis U.S., this ... Through his professional life, Dr. Stamm has worked ...
... (Washington, D.C. July 14, 2008) EPA has released ... Criteria." This is EPA,s latest evaluation of the ... resulting from exposures to oxides of nitrogen, particularly nitrogen ... data, particularly epidemiological studies, since the last scientific review ...
... 2008 The outlook for air quality in Beijing during ... government can do to improve it. That,s the ... who analyzed pollution data collected regularly for the last five ... component and a regional component to the pollutants that cause ...
Cached Biology News:URI researcher: China can't fully fix air quality problem for Olympics 2
... allows the Thermo-Fast® 96 ... PCR plates to be ... PRISM® 3700 capillary sequencer. ... information on the software ...
Spectrolyse (pL) PAI kit is a two-stage indirect enzymatic assay for the quantitative determination of Plasminogen Activator Inhibitor (PAI-1) activity in plasma. Sample Type: plasma...
Rabbit anti-CRSP1 (TRAP220), Polyclonal Antibody, Unconjugated Applications: Immunohistochemistry - 1:100 - 1:500...
... White lyophilized solid. PROTECT FROM LIGHT. PACKAGED ... of γ-secretase. Equipotently inhibits the release of ... 2.6 μM) and Aβ x-42 (ED ... cells stably transfected with the Amyloid Precursor ...
Biology Products: